These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18551932)

  • 21. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.
    Janchawee B; Wongpoowarak W; Owatranporn T; Chongsuvivatwong V
    J Clin Pharm Ther; 2005 Feb; 30(1):13-20. PubMed ID: 15659000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and contributors to potential drug-drug interactions in hospitalized patients.
    Reimche L; Forster AJ; van Walraven C
    J Clin Pharmacol; 2011 Jul; 51(7):1043-50. PubMed ID: 20926752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of potential drug-drug interactions with antidiabetic drugs.
    Samardzic I; Bacic-Vrca V
    Pharmazie; 2015 Jun; 70(6):410-5. PubMed ID: 26189304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of drug interactions in hospitals--computerized screening vs. bedside recording.
    Blix HS; Viktil KK; Moger TA; Reikvam A
    J Clin Pharm Ther; 2008 Apr; 33(2):131-9. PubMed ID: 18315778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective and retrospective study of actinomycosis in last five years at Manipal Teaching Hospital, Pokhara, Nepal.
    Talwar OP; Ghosh A; Pradhan S; Swami RM; Shivraj KC
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):488-91. PubMed ID: 18604080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of mastalgia cases presented at Manipal Teaching Hospital, Pokhara, Nepal.
    Shrestha S; Sen T
    Nepal Med Coll J; 2004 Dec; 6(2):129-32. PubMed ID: 16295745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential determinants of prescribers' drug-drug interaction knowledge.
    Ko Y; Malone DC; D'Agostino JV; Skrepnek GH; Armstrong EP; Brown M; Woosley RL
    Res Social Adm Pharm; 2008 Dec; 4(4):355-66. PubMed ID: 19064242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective surveillance of drug prescribing and dispensing in a teaching hospital in western Nepal.
    Ghimire S; Nepal S; Bhandari S; Nepal P; Palaian S
    J Pak Med Assoc; 2009 Oct; 59(10):726-31. PubMed ID: 19813695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of drug-drug interactions (DDIs) in nursing homes in Central Taiwan.
    Liao HL; Chen JT; Ma TC; Chang YS
    Arch Gerontol Geriatr; 2008; 47(1):99-107. PubMed ID: 17868936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug utilization pattern and effectiveness analysis in diabetes mellitus at a tertiary care centre in eastern Nepal.
    Das P; Das BP; Rauniar GP; Roy RK; Sharma SK
    Indian J Physiol Pharmacol; 2011; 55(3):272-80. PubMed ID: 22471235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
    P V K; Palaian S; Ojha P; P R S
    Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of potential drug interactions among patients receiving anti-hypertensive medications.
    Sweileh WM; Sawalha AF; Jaradat NA
    Saudi Med J; 2005 Apr; 26(4):548-52. PubMed ID: 15900357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential for drug interactions in hospitalized cancer patients.
    Riechelmann RP; Moreira F; Smaletz O; Saad ED
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):286-90. PubMed ID: 15731916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database.
    Nobili A; Pasina L; Tettamanti M; Lucca U; Riva E; Marzona I; Monesi L; Cucchiani R; Bortolotti A; Fortino I; Merlino L; Walter Locatelli G; Giuliani G
    J Clin Pharm Ther; 2009 Aug; 34(4):377-86. PubMed ID: 19583670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
    Magro L; Moretti U; Leone R
    Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-center hemodialysis for end stage kidney disease at Nepal Medical College and Teaching Hospital.
    Chhetri PK; Manandhar DN; Tiwari R; Lamichhane S
    Nepal Med Coll J; 2009 Mar; 11(1):61-3. PubMed ID: 19769242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.